OpenURL Connection Search

Select item for more details and to access through your institution.

Comparative effectiveness of 6x R-CHOP21 versus 6x R-CHOP21 + 2 R for patients with advanced-stage diffuse large B-cell lymphoma.
Published in:
Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01137-0
By:
- Maas, Carolien C. H. M.;
- van Klaveren, David;
- Durmaz, Müjde;
- Visser, Otto;
- Issa, Djamila E.;
- Posthuma, Eduardus F. M.;
- Zijlstra, Josée M.;
- Chamuleau, Martine E. D.;
- Lugtenburg, Pieternella J.;
- Kersten, Marie José;
- Dinmohamed, Avinash G.
Publication type:
Article
Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands.
Published in:
Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-023-00970-z
By:
- Pennings, Elise R. A.;
- Durmaz, Müjde;
- Visser, Otto;
- Posthuma, Eduardus F. M.;
- Issa, Djamila E.;
- Chamuleau, Martine E. D.;
- Lugtenburg, Pieternella J.;
- Kersten, Marie José;
- Dinmohamed, Avinash G.
Publication type:
Article
A population-based study of transformed marginal zone lymphoma: identifying outcome-related characteristics.
Published in:
Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00903-w
By:
- Bult, Johanna A. A.;
- Huisman, Francien;
- Zhong, Yujie;
- Veltmaat, Nick;
- Kluiver, Joost;
- Tonino, Sanne H.;
- Vermaat, Joost S. P.;
- Chamuleau, Martine E. D.;
- Diepstra, Arjan;
- van den Berg, Anke;
- Plattel, Wouter J.;
- Brink, Mirian;
- Nijland, Marcel
Publication type:
Article
Alternative Ii-independent antigen-processing pathway in leukemic blasts involves TAP-dependent peptide loading of HLA class II complexes.
Published in:
Cancer Immunology, Immunotherapy, 2010, v. 59, n. 12, p. 1825, doi. 10.1007/s00262-010-0908-z
By:
- van Luijn, Marvin M.;
- Chamuleau, Martine E. D.;
- Ressing, Maaike E.;
- Wiertz, Emmanuel J.;
- Ostrand-Rosenberg, Suzanne;
- Souwer, Yuri;
- Zevenbergen, Adri;
- Ossenkoppele, Gert J.;
- van de Loosdrecht, Arjan A.;
- van Ham, S. Marieke
Publication type:
Article
The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands.
Published in:
Cancers, 2023, v. 15, n. 17, p. 4334, doi. 10.3390/cancers15174334
By:
- Spanjaart, Anne M.;
- Pennings, Elise R. A.;
- Mutsaers, Pim G. N. J.;
- van Dorp, Suzanne;
- Jak, Margot;
- van Doesum, Jaap A.;
- de Boer, Janneke W.;
- Niezink, Anne G. H.;
- Kos, Milan;
- Vermaat, Joost S. P.;
- Sijs-Szabo, Aniko;
- van der Poel, Marjolein W. M.;
- Nijhof, Inger S.;
- Kuipers, Maria T.;
- Chamuleau, Martine E. D.;
- Lugtenburg, Pieternella J.;
- Doorduijn, Jeanette K.;
- Serroukh, Yasmina I. M.;
- Minnema, Monique C.;
- van Meerten, Tom
Publication type:
Article
Biological and Clinical Implications of Gene-Expression Profiling in Diffuse Large B-Cell Lymphoma: A Proposal for a Targeted BLYM-777 Consortium Panel as Part of a Multilayered Analytical Approach.
Published in:
Cancers, 2022, v. 14, n. 8, p. 1857, doi. 10.3390/cancers14081857
By:
- de Groot, Fleur A.;
- de Groen, Ruben A. L.;
- van den Berg, Anke;
- Jansen, Patty M.;
- Lam, King H.;
- Mutsaers, Pim G. N. J.;
- van Noesel, Carel J. M.;
- Chamuleau, Martine E. D.;
- Stevens, Wendy B. C.;
- Plaça, Jessica R.;
- Mous, Rogier;
- Kersten, Marie José;
- van der Poel, Marjolein M. W.;
- Tousseyn, Thomas;
- Woei-a-Jin, F. J. Sherida H.;
- Diepstra, Arjan;
- Nijland, Marcel;
- Vermaat, Joost S. P.
Publication type:
Article
Impact of MYC on Anti-Tumor Immune Responses in Aggressive B Cell Non-Hodgkin Lymphomas: Consequences for Cancer Immunotherapy.
Published in:
Cancers, 2020, v. 12, n. 10, p. 3052, doi. 10.3390/cancers12103052
By:
- de Jonge, A. Vera;
- Mutis, Tuna;
- Roemer, Margaretha G. M.;
- Scheijen, Blanca;
- Chamuleau, Martine E. D.
Publication type:
Article
Fc-Engineered Antibodies with Enhanced Fc-Effector Function for the Treatment of B-Cell Malignancies.
Published in:
Cancers, 2020, v. 12, n. 10, p. 3041, doi. 10.3390/cancers12103041
By:
- van der Horst, Hilma J.;
- Nijhof, Inger S.;
- Mutis, Tuna;
- Chamuleau, Martine E. D.
Publication type:
Article
ZAP70 in B-CLL cells related to the expression in NK cells is a surrogate marker for mutational status.
Published in:
Cytometry. Part B, 2014, v. 86, n. 4, p. 280, doi. 10.1002/cyto.b.21132
By:
- Wiggers, Tom G. H.;
- Westra, Guus;
- Westers, Theresia M.;
- Abbes, Andre P.;
- Strunk, Annuska;
- Kuiper‐Kramer, Ellen;
- Poddighe, Pino;
- Loosdrecht, Arjan A.;
- Chamuleau, Martine E. D.
Publication type:
Article
First-Line Treatment of Waldenström's Macroglobulinaemia: Considerations Based on the Dutch National Guideline.
Published in:
Hemato, 2022, v. 3, n. 4, p. 704, doi. 10.3390/hemato3040047
By:
- Amaador, Karima;
- Kersten, Marie José;
- Visser, Hein P. J.;
- Nieuwenhuizen, Laurens;
- Schop, Roelandt F. J.;
- Chamuleau, Martine E. D.;
- Velders, Gerjo A.;
- Minnema, Monique C.;
- Vos, Josephine Mathilde Iris
Publication type:
Article
Chemotherapy resistant Burkitt lymphoma: Possible novel therapies including CAR‐T cell infusion.
Published in:
2023
By:
- Geerts, Paulus A. F.;
- 't Hart, Nils;
- Visser, Otto;
- Ortiz‐Maldonado, Valentín;
- Chamuleau, Martine E. D.
Publication type:
Case Study
18F-FDG or 3'-Deoxy-3'-18F-Fluorothymidine to Detect Transformation of Follicular Lymphoma.
Published in:
Journal of Nuclear Medicine, 2015, v. 56, n. 2, p. 216, doi. 10.2967/jnumed.114.149625
By:
- Wondergem, Marielle J.;
- Rizvi, Saiyada N. F.;
- Jauw, Yvonne;
- Hoekstra, Otto S.;
- Hoetjes, Nikie;
- de Ven, Peter M. van;
- Boellaard, Ronald;
- Chamuleau, Martine E. D.;
- Cillessen, Saskia A. G. M.;
- Regelink, Josien C.;
- Zweegman, Sonja;
- Zijlstra, Josée M.
Publication type:
Article
A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients.
Published in:
Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00854-2
By:
- de Jonge, A. Vera;
- van Werkhoven, Erik;
- Dinmohamed, Avinash G.;
- Nijland, Marcel;
- Zwinderman, Aeilko H.;
- Bossuyt, Patrick M.;
- Veldhuis, Martine S.;
- Rutten, Emma G. G. M.;
- Mous, Rogier;
- Vermaat, Joost S. P.;
- Sandberg, Yorick;
- de Jongh, Eva;
- Bilgin, Yavuz M.;
- Boersma, Rinske;
- Koene, Harry;
- Kersten, Marie José;
- de Jong, Daphne;
- Chamuleau, Martine E. D.
Publication type:
Article
A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients.
Published in:
Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00854-2
By:
- de Jonge, A. Vera;
- van Werkhoven, Erik;
- Dinmohamed, Avinash G.;
- Nijland, Marcel;
- Zwinderman, Aeilko H.;
- Bossuyt, Patrick M.;
- Veldhuis, Martine S.;
- Rutten, Emma G. G. M.;
- Mous, Rogier;
- Vermaat, Joost S. P.;
- Sandberg, Yorick;
- de Jongh, Eva;
- Bilgin, Yavuz M.;
- Boersma, Rinske;
- Koene, Harry;
- Kersten, Marie José;
- de Jong, Daphne;
- Chamuleau, Martine E. D.
Publication type:
Article
R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma.
Published in:
Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00723-4
By:
- Al-Sarayfi, Diana;
- Meeuwes, Frederik O.;
- Durmaz, Müjde;
- Issa, Djamila E.;
- Brouwer, Rolf E.;
- Beeker, Aart;
- van Rhenen, Anna;
- Mutsaers, Pim G. N. J.;
- Böhmer, Lara H.;
- van der Poel, Marjolein W. M.;
- te Boome, Liane;
- van Meerten, Tom;
- Chamuleau, Martine E. D.;
- Zijlstra, Josée M.;
- Brink, Mirian;
- Nijland, Marcel
Publication type:
Article
Time trends in primary therapy and relative survival of diffuse large B-cell lymphoma by stage: a nationwide, population-based study in the Netherlands, 1989–2018.
Published in:
Blood Cancer Journal, 2022, v. 12, n. 3, p. 1, doi. 10.1038/s41408-022-00637-1
By:
- Durmaz, Müjde;
- Visser, Otto;
- Posthuma, Eduardus F. M.;
- Brouwer, Rolf E.;
- Issa, Djamila E.;
- de Jong, Daphne;
- Lam, King H.;
- Blijlevens, Nicole M. A.;
- Zijlstra, Josée M.;
- Chamuleau, Martine E. D.;
- Lugtenburg, Pieternella J.;
- Kersten, Marie José;
- Dinmohamed, Avinash G.
Publication type:
Article
Epcoritamab induces potent anti-tumor activity against malignant B-cells from patients with DLBCL, FL and MCL, irrespective of prior CD20 monoclonal antibody treatment.
Published in:
Blood Cancer Journal, 2021, v. 11, n. 2, p. 1, doi. 10.1038/s41408-021-00430-6
By:
- van der Horst, Hilma J.;
- de Jonge, A. Vera;
- Hiemstra, Ida H.;
- Gelderloos, Anne T.;
- Berry, Daniella R. A. I.;
- Hijmering, Nathalie J.;
- van Essen, Hendrik F.;
- de Jong, Daphne;
- Chamuleau, Martine E. D.;
- Zweegman, Sonja;
- Breij, Esther C. W.;
- Roemer, Margaretha G. M.;
- Mutis, Tuna
Publication type:
Article
DuoHexaBody-CD37®, a novel biparatopic CD37 antibody with enhanced Fc-mediated hexamerization as a potential therapy for B-cell malignancies.
Published in:
Blood Cancer Journal, 2020, v. 10, n. 3, p. 1, doi. 10.1038/s41408-020-0292-7
By:
- Oostindie, Simone C.;
- van der Horst, Hilma J.;
- Kil, Laurens P.;
- Strumane, Kristin;
- Overdijk, Marije B.;
- van den Brink, Edward N.;
- van den Brakel, Jeroen H. N.;
- Rademaker, Hendrik J.;
- van Kessel, Berris;
- van den Noort, Juliette;
- Chamuleau, Martine E. D.;
- Mutis, Tuna;
- Lindorfer, Margaret A.;
- Taylor, Ronald P.;
- Schuurman, Janine;
- Parren, Paul W. H. I.;
- Beurskens, Frank J.;
- Breij, Esther C. W.
Publication type:
Article
Genomic profiling of post-transplant lymphoproliferative disorders using cell-free DNA.
Published in:
Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01500-x
By:
- Veltmaat, Nick;
- Zhong, Yujie;
- de Jesus, Filipe Montes;
- Tan, Geok Wee;
- Bult, Johanna A. A.;
- Terpstra, Martijn M.;
- Mutsaers, Pim G. N. J.;
- Stevens, Wendy B. C.;
- Mous, Rogier;
- Vermaat, Joost S. P.;
- Chamuleau, Martine E. D.;
- Noordzij, Walter;
- Verschuuren, Erik A. M.;
- Kok, Klaas;
- Kluiver, Joost L.;
- Diepstra, Arjan;
- Plattel, Wouter J.;
- van den Berg, Anke;
- Nijland, Marcel
Publication type:
Article
Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
Published in:
British Journal of Haematology, 2009, v. 145, n. 3, p. 334, doi. 10.1111/j.1365-2141.2009.07625.x
By:
- Souwer, Yuri;
- Chamuleau, Martine E. D.;
- van de Loosdrecht, Arjan A.;
- Tolosa, Eva;
- Jorritsma, Tineke;
- Muris, Jettie J. F.;
- Dinnissen-van Poppel, Marion J.;
- Snel, Sander N.;
- van de Corput, Lisette;
- Ossenkoppele, Gert J.;
- Meijer, Chris J. L. M.;
- Neefjes, Jacques J.;
- Marieke van Ham, S.
Publication type:
Article
The path towards consensus genome classification of diffuse large B-cell lymphoma for use in clinical practice.
Published in:
Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.970063
By:
- Mendeville, Matias;
- Roemer, Margaretha G. M.;
- Los-de Vries, G. Tjitske;
- Chamuleau, Martine E. D.;
- de Jong, Daphne;
- Ylstra, Bauke
Publication type:
Article
An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patients.
Published in:
Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-40218-1
By:
- Ferrández, Maria C.;
- Golla, Sandeep S. V.;
- Eertink, Jakoba J.;
- de Vries, Bart M.;
- Lugtenburg, Pieternella J.;
- Wiegers, Sanne E.;
- Zwezerijnen, Gerben J. C.;
- Pieplenbosch, Simone;
- Kurch, Lars;
- Hüttmann, Andreas;
- Hanoun, Christine;
- Dührsen, Ulrich;
- de Vet, Henrica C. W.;
- PETRA;
- Hoekstra, Otto S.;
- Burggraaff, Coreline N.;
- Bes, Annelies;
- Heymans, Martijn W.;
- Jauw, Yvonne W. S.;
- Chamuleau, Martine E. D.
Publication type:
Article

Found: 22

Comparative effectiveness of 6x R-CHOP21 versus 6x R-CHOP21 + 2 R for patients with advanced-stage diffuse large B-cell lymphoma.

Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands.

A population-based study of transformed marginal zone lymphoma: identifying outcome-related characteristics.

Alternative Ii-independent antigen-processing pathway in leukemic blasts involves TAP-dependent peptide loading of HLA class II complexes.

The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands.

Biological and Clinical Implications of Gene-Expression Profiling in Diffuse Large B-Cell Lymphoma: A Proposal for a Targeted BLYM-777 Consortium Panel as Part of a Multilayered Analytical Approach.

Impact of MYC on Anti-Tumor Immune Responses in Aggressive B Cell Non-Hodgkin Lymphomas: Consequences for Cancer Immunotherapy.

Fc-Engineered Antibodies with Enhanced Fc-Effector Function for the Treatment of B-Cell Malignancies.

ZAP70 in B-CLL cells related to the expression in NK cells is a surrogate marker for mutational status.

First-Line Treatment of Waldenström's Macroglobulinaemia: Considerations Based on the Dutch National Guideline.

Chemotherapy resistant Burkitt lymphoma: Possible novel therapies including CAR‐T cell infusion.

<sup>18</sup>F-FDG or 3'-Deoxy-3'-<sup>18</sup>F-Fluorothymidine to Detect Transformation of Follicular Lymphoma.

A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients.

A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients.

R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma.

Time trends in primary therapy and relative survival of diffuse large B-cell lymphoma by stage: a nationwide, population-based study in the Netherlands, 1989–2018.

Epcoritamab induces potent anti-tumor activity against malignant B-cells from patients with DLBCL, FL and MCL, irrespective of prior CD20 monoclonal antibody treatment.

DuoHexaBody-CD37<sup>®</sup>, a novel biparatopic CD37 antibody with enhanced Fc-mediated hexamerization as a potential therapy for B-cell malignancies.

Genomic profiling of post-transplant lymphoproliferative disorders using cell-free DNA.

Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.

The path towards consensus genome classification of diffuse large B-cell lymphoma for use in clinical practice.

An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patients.